Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 53.58 Billion SEK | 2.99% |
| 2022 | 52.03 Billion SEK | 16.78% |
| 2021 | 44.55 Billion SEK | -1.02% |
| 2020 | 45.01 Billion SEK | 0.67% |
| 2019 | 44.71 Billion SEK | 3.14% |
| 2018 | 43.35 Billion SEK | 2.97% |
| 2017 | 42.1 Billion SEK | -23.74% |
| 2016 | 55.21 Billion SEK | 3.71% |
| 2015 | 53.23 Billion SEK | 0.79% |
| 2014 | 52.81 Billion SEK | 19.22% |
| 2013 | 44.3 Billion SEK | 3.22% |
| 2012 | 42.92 Billion SEK | 3.5% |
| 2011 | 41.46 Billion SEK | 19.9% |
| 2010 | 34.58 Billion SEK | -7.77% |
| 2009 | 37.49 Billion SEK | 13.52% |
| 2008 | 33.03 Billion SEK | 43.67% |
| 2007 | 22.99 Billion SEK | 44.81% |
| 2006 | 15.87 Billion SEK | 9.25% |
| 2005 | 14.53 Billion SEK | 16.66% |
| 2004 | 12.45 Billion SEK | 3.53% |
| 2003 | 12.03 Billion SEK | 26.95% |
| 2002 | 9.47 Billion SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 55.23 Billion SEK | -1.93% |
| 2024 Q3 | 59.61 Billion SEK | 7.94% |
| 2024 Q1 | 56.32 Billion SEK | 5.1% |
| 2023 Q4 | 53.58 Billion SEK | 0.09% |
| 2023 Q1 | 50.98 Billion SEK | -2.01% |
| 2023 Q2 | 52.71 Billion SEK | 3.39% |
| 2023 Q3 | 53.54 Billion SEK | 1.57% |
| 2023 FY | 53.58 Billion SEK | 2.99% |
| 2022 Q4 | 52.03 Billion SEK | 0.24% |
| 2022 Q2 | 48.48 Billion SEK | 6.66% |
| 2022 Q1 | 45.45 Billion SEK | 2.01% |
| 2022 Q3 | 51.9 Billion SEK | 7.07% |
| 2022 FY | 52.03 Billion SEK | 16.78% |
| 2021 Q2 | 41.66 Billion SEK | -7.07% |
| 2021 FY | 44.55 Billion SEK | -1.02% |
| 2021 Q4 | 44.55 Billion SEK | 2.64% |
| 2021 Q3 | 43.4 Billion SEK | 4.2% |
| 2021 Q1 | 44.83 Billion SEK | -0.41% |
| 2020 Q4 | 45.01 Billion SEK | -6.66% |
| 2020 FY | 45.01 Billion SEK | 0.67% |
| 2020 Q1 | 48.28 Billion SEK | 7.99% |
| 2020 Q2 | 49.33 Billion SEK | 2.18% |
| 2020 Q3 | 48.22 Billion SEK | -2.25% |
| 2019 Q3 | 46.57 Billion SEK | 3.34% |
| 2019 Q2 | 45.07 Billion SEK | 0.59% |
| 2019 FY | 44.71 Billion SEK | 3.14% |
| 2019 Q1 | 44.81 Billion SEK | 3.36% |
| 2019 Q4 | 44.71 Billion SEK | -4.0% |
| 2018 Q2 | 43.46 Billion SEK | 3.36% |
| 2018 Q4 | 43.35 Billion SEK | 1.71% |
| 2018 FY | 43.35 Billion SEK | 2.97% |
| 2018 Q3 | 42.62 Billion SEK | -1.93% |
| 2018 Q1 | 42.05 Billion SEK | -0.12% |
| 2017 FY | 42.1 Billion SEK | -23.74% |
| 2017 Q1 | 54.82 Billion SEK | -0.7% |
| 2017 Q3 | 51.65 Billion SEK | -2.24% |
| 2017 Q2 | 52.83 Billion SEK | -3.63% |
| 2017 Q4 | 42.1 Billion SEK | -18.5% |
| 2016 Q4 | 55.21 Billion SEK | 1.77% |
| 2016 FY | 55.21 Billion SEK | 3.71% |
| 2016 Q3 | 54.25 Billion SEK | 1.3% |
| 2016 Q2 | 53.55 Billion SEK | 2.23% |
| 2016 Q1 | 52.38 Billion SEK | -1.59% |
| 2015 Q4 | 53.23 Billion SEK | -0.6% |
| 2015 FY | 53.23 Billion SEK | 0.79% |
| 2015 Q3 | 53.55 Billion SEK | 0.24% |
| 2015 Q2 | 53.43 Billion SEK | -3.83% |
| 2015 Q1 | 55.55 Billion SEK | 5.19% |
| 2014 Q2 | 46.94 Billion SEK | 3.57% |
| 2014 Q3 | 48.69 Billion SEK | 3.72% |
| 2014 Q4 | 52.81 Billion SEK | 8.47% |
| 2014 Q1 | 45.32 Billion SEK | 2.32% |
| 2014 FY | 52.81 Billion SEK | 19.22% |
| 2013 Q2 | 44.02 Billion SEK | 2.71% |
| 2013 Q1 | 42.86 Billion SEK | -0.14% |
| 2013 Q4 | 44.3 Billion SEK | 2.54% |
| 2013 FY | 44.3 Billion SEK | 3.22% |
| 2013 Q3 | 43.2 Billion SEK | -1.85% |
| 2012 Q2 | 41.17 Billion SEK | 3.33% |
| 2012 Q4 | 42.92 Billion SEK | 5.78% |
| 2012 FY | 42.92 Billion SEK | 3.5% |
| 2012 Q1 | 39.85 Billion SEK | -3.9% |
| 2012 Q3 | 40.57 Billion SEK | -1.47% |
| 2011 FY | 41.46 Billion SEK | 19.9% |
| 2011 Q4 | 41.46 Billion SEK | 19.12% |
| 2011 Q3 | 34.81 Billion SEK | 4.42% |
| 2011 Q2 | 33.33 Billion SEK | 0.15% |
| 2011 Q1 | 33.28 Billion SEK | -3.75% |
| 2010 Q1 | 36.34 Billion SEK | -3.08% |
| 2010 Q2 | 37.42 Billion SEK | 2.98% |
| 2010 Q4 | 34.58 Billion SEK | -0.02% |
| 2010 Q3 | 34.59 Billion SEK | -7.57% |
| 2010 FY | 34.58 Billion SEK | -7.77% |
| 2009 Q4 | 37.49 Billion SEK | 0.0% |
| 2009 FY | 37.49 Billion SEK | 13.52% |
| 2008 FY | 33.03 Billion SEK | 43.67% |
| 2007 FY | 22.99 Billion SEK | 44.81% |
| 2006 FY | 15.87 Billion SEK | 9.25% |
| 2005 FY | 14.53 Billion SEK | 16.66% |
| 2004 FY | 12.45 Billion SEK | 3.53% |
| 2003 FY | 12.03 Billion SEK | 26.95% |
| 2002 FY | 9.47 Billion SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AVITA Medical, Inc. | 144.33 Million USD | -37024.847% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -16957494.937% |
| Össur hf. | 1.39 Billion USD | -3744.564% |
| QHSLab, Inc. | 1.68 Million USD | -3186826.382% |
| Wellstar International, Inc. | 957.89 Thousand USD | -5594058.84% |
| Össur hf. | 1.39 Billion USD | -3744.564% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | -1126147.261% |
| Aurora Spine Corporation | 11.92 Million USD | -449305.372% |
| BrainsWay Ltd. | 62.97 Million USD | -84994.963% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | -37112402.424% |
| Hamilton Thorne Ltd. | 110.16 Million USD | -48542.276% |
| Vivos Inc. | 1.61 Million USD | -3327966.658% |
| Kelyniam Global, Inc. | 1.63 Million USD | -3281960.202% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -4442027.008% |
| Zecotek Photonics Inc. | 2.57 Million USD | -2082613.894% |
| Avitar, Inc. | 1.74 Million USD | -3065767.578% |
| Nanomix Corporation | 982.05 Thousand USD | -5456417.201% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | -51965.289% |
| Theraclion SA | 18.66 Million EUR | -287015.488% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | -3031382.477% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -7160137.472% |
| Lombard Medical, Inc. | 67.76 Million USD | -78973.886% |
| ALR Technologies Inc. | 193.21 Thousand USD | -27733484.519% |
| Stratec SE | 529.71 Million USD | -10016.026% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -5400092.281% |
| Heart Tronics, Inc. | 4.04 Million USD | -1323358.805% |
| MicroPort Scientific Corporation | 3.93 Billion USD | -1263.047% |
| VMS Rehab Systems, Inc. | 4.45 USD | -1204179775180.899% |
| NewCardio, Inc. | 2.85 Million USD | -1878097.889% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -3210565.069% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -7263454.27% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -11756552.691% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -97877448.038% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -29413666.604% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -238952.463% |
| IR-Med Inc. | 999 Thousand USD | -5363863.964% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -260768.664% |
| Polarean Imaging plc | 10.86 Million USD | -492995.549% |
| United American Healthcare Corporation | 10.37 Million USD | -516192.514% |
| ECGI Holdings, Inc. | 5.2 Million USD | -1030121.048% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -2422375.232% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -158566509.457% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -2505407.947% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -6153756.755% |
| Urologix, Inc. | 5.66 Million USD | -945479.672% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -2376661.969% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -263203.184% |
| SS Innovations International, Inc. | 25.47 Million USD | -210213.667% |
| Qualis Innovations, Inc. | 2431.00 USD | -2204277974.866% |
| Smith & Nephew plc | 9.97 Billion USD | -437.316% |
| NIOX Group Plc | 116.47 Million USD | -45904.662% |
| Fuse Medical, Inc. | 16.25 Million USD | -329473.938% |
| Broncus Holding Corporation | 195.75 Million USD | -27274.451% |
| Brain Scientific Inc. | 11.74 Million USD | -456198.63% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -5104903.83% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -186483282.634% |